CUV 2.87% $15.39 clinuvel pharmaceuticals limited

Ann: CLINUVEL Newsletter II - March 2024, page-2

  1. 768 Posts.
    lightbulb Created with Sketch. 973
    I have never heard such an amazing and bullish statement from a company intent on restoring market valuation. This was in reference to a FIRST share buyback.

    "We have chosen the moment of a repurchase as first clinical results for 2024 are published, and we will
    keep at it until those who gamble against the Company have understood the message. Given the
    expected future cash flows, we are in the position to prolong the program when required"


    That is really great, as I mentioned the buyback is only using a tiny percentage of cash reserves and when it's completed they will have banked another $30+ Million in cash and can easily go again. Sounds like they have had enough of the manipulation too and are intent on changing the narrative.

    All IMO DYOR



 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
(20min delay)
Last
$15.39
Change
0.430(2.87%)
Mkt cap ! $771.0M
Open High Low Value Volume
$14.96 $15.39 $14.83 $2.149M 141.3K

Buyers (Bids)

No. Vol. Price($)
1 590 $15.29
 

Sellers (Offers)

Price($) Vol. No.
$15.41 1079 1
View Market Depth
Last trade - 16.10pm 21/06/2024 (20 minute delay) ?
CUV (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.